loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Diclofenac Diethylamine

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Diclofenac Diethylamine

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 47Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NPPA panel fixes retail price of Diclofenac transdermal patch
    NPPA panel fixes retail price of Diclofenac transdermal patch

    07 Feb 2022

    // MEDICALDIALOGUES

    https://medicaldialogues.in/news/industry/pharma/nppa-panel-fixes-retail-price-of-diclofenac-transdermal-patch-marketed-by-hetero-healthcare-88215

    MEDICALDIALOGUES
    07 Feb 2022
    Share Share
    Novartis manufacturing agreement cited in Syria controversy
    Novartis manufacturing agreement cited in Syria controversy

    27 Jun 2019

    // FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/novartis-manufacturing-agreement-cited-syria-controversy

    FIERCE PHARMA
    27 Jun 2019
    Share Share